Effects of arginine vasopressin and oxytocin on glucagon release from clonal α-cell line in-R1-G9: Involvement of V(1b) receptors

Life Sciences

Volumn 63, Issue 21, 1998, Pages 1871-1878

  Yibchok Anun, Sirintorn ^a   Hsu, Walter H ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

Arginine vasopressin; Glucagon; Oxytocin; Pancreatic cells; V(1b) receptor

Indexed keywords

ARGIPRESSIN; CORTICOTROPIN; GLUCAGON; GLUCAGON RECEPTOR; L 366948; OXYTOCIN ANTAGONIST; UNCLASSIFIED DRUG; VASOPRESSIN;

ANIMAL EXPERIMENT; ARTICLE; CALCULATION; CELL LINE; GLUCAGON RELEASE; GLUCAGONOMA; GLUCONEOGENESIS; HAMSTER; MAMMAL; NONHUMAN; PANCREAS ISLET ALPHA CELL; PEPTIDE SYNTHESIS; STATISTICAL ANALYSIS;

ANIMALS; ARGININE VASOPRESSIN; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCAGON; GLUCAGONOMA; HORMONE ANTAGONISTS; ISLETS OF LANGERHANS; OXYTOCIN; PANCREATIC NEOPLASMS; PEPTIDES, CYCLIC; RECEPTORS, OXYTOCIN; RECEPTORS, VASOPRESSIN; RENAL AGENTS; TUMOR CELLS, CULTURED;

ANIMALIA; CRICETINAE; MAMMALIA;

EID: 0032538480     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(98)00463-9     Document Type: Article

References (25)

1. 1. N. ALTSZULER and HAMSHIRE, Diabetes 30 112-114 (1981).
2. 2. J.A. AMICO, F.M. FINN and J. HALDAR, Am. J. Med. Sci. 269 303-307 (1988).
3. 3. B.E. DUNNING, J.H. MOLTZ and C.P. FAWCETT, Peptides 5 871-875 (1984).
4. 4. C. YANG and W.H. HSU, Am. J. Physiol. 268 (Endocrinol. Metab. 31) E1027-E1030 (1995).
5. 5. B.E. DUNNING, J.H. MOLTZ and C.P. FAWCETT, Am. J. Physiol. 246 (Endrocrinol. Metab. 9) E108-E114 (1984).
6. 6. C.J. KIRK, L.M. RODRIGUES and D.A. HEMS, Biochem. J. 178 493-496 (1979).
7. 7. R.H. MICHELL, C.J. KIRK and M.M. BILLAH, Biochem. Soc. Trans. 7 861-865 (1979).
8. 8. A.W. FOX, P.A. FRIEDMAN, P.W. ABEL, Eur. J. Pharmacol. 135 1-10 (1987).
9. 9. M. THIBONNIER, Regul. Pept. 38 1-11 (1992).
10. 10. F.A. ANTONI, M.C. HOLMES, G.B. MAKARA, M. KARTESZI and F.A. LASZLO, Peptides 5 519-522 (1984).
11. 11. F.A. ANTONI, Neuroendocrinology 39 186-188(1984).
12. 12. E. GRAZZINI, A.M. LODBOERER, A. PEREZ-MARTIN, D. JOUBERT, and G. GUILLON, Endocrinology 137 3906-3914 (1996).
13. 13. B. LEE, C. YANG, T.H. CHEN, N. AL-AZAWI, and W.H. HSU, Am. J. Physiol. 269 (Endrocrinol. Metab. 32) E1095-E1100 (1995).
14. 14. S. JARD, Curr. Top. Membr. Transp. 18 255-285 (1983).
15. 15. M. THIBONNIER, Presse Med. 16 481-485 (1987).
16. 16. H. YU, R. ZHUGE, and W.H. HSU, Biol. Reprod. 52 584-590 (1995).
17. 17. S.F. SCHLOSSER, O.F.X. ALMEIDA, V.K. PATCHEV, A. YASSOURIDIS, and J. ELANDS, Endocrinology 135 2058-2063 (1994).
18. 18. M. MANNING, and W.H. SAWYER, J. Lab. Clin. Med. 114 617-632 (1989).
19. 19. J. SCHWARTZ, I. DERDOWSKA, M. SOBOCINSKA, and G. KUPRYSZEWSKI, Endocrinology 129 1107-1109 (1991).
20. 20. P.D. WILLIAMS, M.G. BOCK, R.D. TUNG, V.M. GARSKY, D.S. PERLOW, J.M. ERB, G.F. LUNDELL, N.P. GOULD, W.L. WHITTER, J.B. HOFFMAN, M.J. KAUFMAN, B.V. CLINESCHMIDT, D.J. PETTIBONE, R.M. FREIDINGER, and D.F. VEBER, J. Med. Chem. 35 3905-3918 (1992).
21. 21. S. JARD, R.C. GAILARD, G. GUILLON, J. MARIE, P. SCHOENENBERG, A.F. MULLER, M. MANNING, and W.H. SAWYER, Mol. Pharmacol. 30 171-177 (1986).
22. 22. M. THIBONNIER, J.A. PRESTON, N. DULIN, P.L. WILKINS, L.N. BERTI-MATTERA and R. MATTERA, Endocrinology 138 4109-4122 (1997).
23. 23. M. MANNING, A. MISICKA, A. OLMA, W.A KLIS, K. BANKOWSKI, E. NAWROCKA, M. KRUSZYNSKI, A. KOLODZIEJCZYK, L.L. CHENG, J. SETO, N.C. WO, and W.H. SAWYER, J. Med. Chem. 30 2245-2252 (1987).
24. 24. M. MANNING, K. BANKOWSKI, C. BARBERIS, S. JARD, J. ELANDS and W.Y. CHAN, Int. J. Pept. Protein Res. 40 261-267 (1992).
25. 25. M. SAITO, T. SUMIMOTO, A. TAHARA, and H. KAWASHIMA, Biochem. Biophys Res. Commun. 212 751-757 (1995).